The DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Homologous recombination in cancer development, treatment and development of drug resistance
Abstract
Although DNA double-strand breaks (DSBs) are substrates for homologous recombination (HR) repair, it is becoming apparent that DNA lesions produced at replication forks, for instance by many anticancer drugs, are more significant substrates for HR repair. Cells defective in HR are hypersensitive to a wide variety of anticancer drugs, including those that do not produce DSBs. Several cancers have mutations in or epigenetically silenced HR genes, which explain the genetic instability that drives cancer development. There are an increasing number of reports suggesting that mutation or epigenetic silencing of HR genes explains the sensitivity of cancers to current chemotherapy treatments. Furthermore, there are also many examples of re-expression of HR genes in tumours to explain drug resistance. Emerging data suggest that there are several different subpathways of HR, which can compensate for each other. Unravelling the overlapping pathways in HR showed that BRCA1- and BRCA2-defective cells rely on the PARP protein for survival. This synthetic lethal interaction is now being exploited for selective treatment of BRCA1- and BRCA2-defective cancers with PARP inhibitors. Here, I discuss the diversity of HR and how it impacts on cancer with a particular focus on how HR can be exploited in future anticancer strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Self-citationGenome maintenance mechanisms for preventing cancer
Hoeijmakers, J. H. J. (2001) · Nature · doi:10.1038/35077232 · Cited by 3,939
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Bartkova, J., Rezaei, N., Liontos, M., Karakaidos, P., Kletsas, D., Issaeva, N., Vassiliou, L.-V. F., Kolettas, E., Niforou, K., Zoumpourlis, V. C., et al. (2006) · Nature · doi:10.1038/nature05268 · Cited by 1,986
Self-citationBortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma
San Miguel, J. F., Schlag, R., Khuageva, N. K., Dimopoulos, M. A., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M. T., Palumbo, A., Samoilova, O. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801479 · Cited by 1,899
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication
Di Micco, R., Fumagalli, M., Cicalese, A., Piccinin, S., Gasparini, P., Luise, C., Schurra, C., Garre’, M., Giovanni Nuciforo, P., Bensimon, A., et al. (2006) · Nature · doi:10.1038/nature05327 · Cited by 1,821
Keeney, S., Giroux, C. N., & Kleckner, N. (1997) · Cell · doi:10.1016/s0092-8674(00)81876-0 · Cited by 1,809
DNA repair pathways as targets for cancer therapy
Helleday, T., Petermann, E., Lundin, C., Hodgson, B., & Sharma, R. A. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2342 · Cited by 1,666
Self-citationPathways of DNA Double-Strand Break Repair during the Mammalian Cell Cycle
Rothkamm, K., Krüger, I., Thompson, L. H., & Lübrich, M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5706-5715.2003 · Cited by 1,189
Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers
Sakai, W., Swisher, E. M., Karlan, B. Y., Agarwal, M. K., Higgins, J., Friedman, C., Villegas, E., Jacquemont, C., Farrugia, D. J., Couch, F. J., et al. (2008) · Nature · doi:10.1038/nature06633 · Cited by 1,086
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G. C. M., Lukas, J., & Jackson, S. P. (2006) · Nature Cell Biology · doi:10.1038/ncb1337 · Cited by 1,064
Resistance to therapy caused by intragenic deletion in BRCA2
Edwards, S. L., Brough, R., Lord, C. J., Natrajan, R., Vatcheva, R., Levine, D. A., Boyd, J., Reis-Filho, J. S., & Ashworth, A. (2008) · Nature · doi:10.1038/nature06548 · Cited by 1,011
BRCA2 Is Required for Homology-Directed Repair of Chromosomal Breaks
Moynahan, M. E., Pierce, A. J., & Jasin, M. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00174-5 · Cited by 1,006
Blunt, T., Finnie, N. J., Taccioli, G. E., Smith, G. C. M., Demengeot, J., Gottlieb, T. M., Mizuta, R., Varghese, A. J., Alt, F. W., Jeggo, P. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90360-7 · Cited by 864
Riballo, E., Kühne, M., Rief, N., Doherty, A., Smith, G. C. M., Recio, M.-J., Reis, C., Dahm, K., Fricke, A., Krempler, A., et al. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.10.029 · Cited by 837
ATM Signaling Facilitates Repair of DNA Double-Strand Breaks Associated with Heterochromatin
Goodarzi, A. A., Noon, A. T., Deckbar, D., Ziv, Y., Shiloh, Y., Löbrich, M., & Jeggo, P. A. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.05.017 · Cited by 836
Petermann, E., Orta, M. L., Issaeva, N., Schultz, N., & Helleday, T. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.021 · Cited by 828
Self-citationTargeted disruption of the Rad51 gene leads to lethality in embryonic mice.
Tsuzuki, T., Fujii, Y., Sakumi, K., Tominaga, Y., Nakao, K., Sekiguchi, M., Matsushiro, A., Yoshimura, Y., & MoritaT (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.13.6236 · Cited by 792
Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death
Sonoda, E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.2.598 · Cited by 791
Lim, D.-S., & Hasty, P. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7133 · Cited by 696
Human Rad51 Protein Promotes ATP-Dependent Homologous Pairing and Strand Transfer Reactions In Vitro
Baumann, P., Benson, F. E., & West, S. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81394-x · Cited by 689
The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair
Sørensen, C. S., Hansen, L. T., Dziegielewski, J., Syljuåsen, R. G., Lundin, C., Bartek, J., & Helleday, T. (2005) · Nature Cell Biology · doi:10.1038/ncb1212 · Cited by 666
Self-citationDNA double-strand break repair: From mechanistic understanding to cancer treatment
HELLEDAY, T., LO, J., VANGENT, D., & ENGELWARD, B. (2007) · DNA Repair · doi:10.1016/j.dnarep.2007.02.006 · Cited by 640
Self-citationInvolvement of Brca2 in DNA Repair
Patel, K. J., Yu, V. P. C. C., Lee, H., Corcoran, A., Thistlethwaite, F. C., Evans, M. J., Colledge, W. H., Friedman, L. S., Ponder, B. A. J., & Venkitaraman, A. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80035-0 · Cited by 634
Murr, R., Loizou, J. I., Yang, Y.-G., Cuenin, C., Li, H., Wang, Z.-Q., & Herceg, Z. (2006) · Nature Cell Biology · doi:10.1038/ncb1343 · Cited by 613
PARP is activated at stalled forks to mediate Mre11‐dependent replication restart and recombination
Bryant, H. E., Petermann, E., Schultz, N., Jemth, A., Loseva, O., Issaeva, N., Johansson, F., Fernandez, S., McGlynn, P., & Helleday, T. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.206 · Cited by 602
Self-citationJohnson, R. D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3398 · Cited by 587
CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle
Yun, M. H., & Hiom, K. (2009) · Nature · doi:10.1038/nature07955 · Cited by 556
ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2
Beucher, A., Birraux, J., Tchouandong, L., Barton, O., Shibata, A., Conrad, S., Goodarzi, A. A., Krempler, A., Jeggo, P. A., & Löbrich, M. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.276 · Cited by 553
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., & D'Andrea, A. D. (2003) · Nature Medicine · doi:10.1038/nm852 · Cited by 536
Frequent chromosomal translocations induced by DNA double-strand breaks
Richardson, C., & Jasin, M. (2000) · Nature · doi:10.1038/35015097 · Cited by 517
Mechanism of Replication-Coupled DNA Interstrand Crosslink Repair
Räschle, M., Knipscheer, P., Enoiu, M., Angelov, T., Sun, J., Griffith, J. D., Ellenberger, T. E., Schärer, O. D., & Walter, J. C. (2008) · Cell · doi:10.1016/j.cell.2008.08.030 · Cited by 511
CDK-dependent phosphorylation of BRCA2 as a regulatory mechanism for recombinational repair
Esashi, F., Christ, N., Gannon, J., Liu, Y., Hunt, T., Jasin, M., & West, S. C. (2005) · Nature · doi:10.1038/nature03404 · Cited by 479
Secondary BRCA1 Mutations in BRCA1 -Mutated Ovarian Carcinomas with Platinum Resistance
Swisher, E. M., Sakai, W., Karlan, B. Y., Wurz, K., Urban, N., & Taniguchi, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0088 · Cited by 457
CDK targets Sae2 to control DNA-end resection and homologous recombination
Huertas, P., Cortés-Ledesma, F., Sartori, A. A., Aguilera, A., & Jackson, S. P. (2008) · Nature · doi:10.1038/nature07215 · Cited by 456
Richardson, C., Moynahan, M. E., & Jasin, M. (1998) · Genes & Development · doi:10.1101/gad.12.24.3831 · Cited by 441
German, J. (1995) · Dermatologic Clinics · doi:10.1016/s0733-8635(18)30101-3 · Cited by 422
Role of Postreplicative DNA Mismatch Repair in the Cytotoxic Action of Thioguanine
Swann, P. F., Waters, T. R., Moulton, D. C., Xu, Y.-Z., Zheng, Q., Edwards, M., & Mace, R. (1996) · Science · doi:10.1126/science.273.5278.1109 · Cited by 408
Hanada, K., Budzowska, M., Davies, S. L., van Drunen, E., Onizawa, H., Beverloo, H. B., Maas, A., Essers, J., Hickson, I. D., & Kanaar, R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1313 · Cited by 390
Arnaudeau, C., Lundin, C., & Helleday, T. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.4564 · Cited by 386
Self-citationLundin, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki681 · Cited by 367
Strumberg, D., Pilon, A. A., Smith, M., Hickey, R., Malkas, L., & Pommier, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.3977-3987.2000 · Cited by 367
Mechanisms of double-strand break repair in somatic mammalian cells
Hartlerode, A. J., & Scully, R. (2009) · Biochemical Journal · doi:10.1042/bj20090942 · Cited by 365
DNA Ligase III as a Candidate Component of Backup Pathways of Nonhomologous End Joining
Wang, H., Rosidi, B., Perrault, R., Wang, M., Zhang, L., Windhofer, F., & Iliakis, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3055 · Cited by 334
Saleh-Gohari, N., Bryant, H. E., Schultz, N., Parker, K. M., Cassel, T. N., & Helleday, T. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.16.7158-7169.2005 · Cited by 333
Self-citationPositional cloning of the gene for Nijmegen breakage syndrome
Matsuura, S., Tauchi, H., Nakamura, A., Kondo, N., Sakamoto, S., Endo, S., Smeets, D., Solder, B., Belohradsky, B. H., Der Kaloustian, V. M., et al. (1998) · Nature Genetics · doi:10.1038/549 · Cited by 328
Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination
Johnson, R. D., Liu, N., & Jasin, M. (1999) · Nature · doi:10.1038/43932 · Cited by 323
Thompson, L. H., Brookman, K. W., Dillehay, L. E., Carrano, A. V., Mazrimas, J. A., Mooney, C. L., & Minkler, J. L. (1982) · Mutation Research · doi:10.1016/0027-5107(82)90276-7 · Cited by 321
Pathways for mitotic homologous recombination in mammalian cells
Helleday, T. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2003.08.013 · Cited by 313
Self-citationMcIlwraith, M. J., Vaisman, A., Liu, Y., Fanning, E., Woodgate, R., & West, S. C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.10.001 · Cited by 306
Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination
Schultz, N. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg703 · Cited by 301
Saleh-Gohari, N. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh703 · Cited by 270
CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer
Teodoridis, J. M., Hall, J., Marsh, S., Kannall, H. D., Smyth, C., Curto, J., Siddiqui, N., Gabra, H., McLeod, H. L., Strathdee, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1187 · Cited by 256
HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination
Adimoolam, S., Sirisawad, M., Chen, J., Thiemann, P., Ford, J. M., & Buggy, J. J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707828104 · Cited by 236
Inhibitors of poly(adenosine diphosphate ribose) polymerase induce sister chromatid exchanges
Oikawa, A., Tohda, H., Kanai, M., Miwa, M., & Sugimura, T. (1980) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(80)80009-x · Cited by 234
Lundin, C., Erixon, K., Arnaudeau, C., Schultz, N., Jenssen, D., Meuth, M., & Helleday, T. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5869-5878.2002 · Cited by 234
Self-citationDNA helicase deficiencies associated with cancer predisposition and premature ageing disorders
Mohaghegh, P. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.741 · Cited by 229
Bianchi, V, Pontis, E., & Reichard, P. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)66672-4 · Cited by 222
Backup pathways of NHEJ in cells of higher eukaryotes: Cell cycle dependence
Iliakis, G. (2009) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.06.024 · Cited by 186
Characterization of a carboxy-terminal BRCA1 interacting protein
Wong, A. K., Ormonde, P. A., Pero, R., Chen, Y., Lian, L., Salada, G., Berry, S., Lawrence, Q., Dayananth, P., Ha, P., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202150 · Cited by 162
Chen, Q., van der Sluis, P. C., Boulware, D. C., Hazlehurst, L., & Dalton, W. S. (2005) · Blood · doi:10.1182/blood-2004-11-4286 · Cited by 151
Mutations of a novel human RAD54 homologue, RAD54B, in primary cancer
Hiramoto, T., Nakanishi, T., Sumiyoshi, T., Fukuda, T., Matsuura, S., Tauchi, H., Komatsu, K., Shibasaki, Y., Inui, H., Watatani, M., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202691 · Cited by 148
Cross-sensitivity of γ-ray-sensitive hamster mutants to cross-linking agents
Caldecott, K. W., & Jeggo, P. A. (1991) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(91)90046-r · Cited by 143
Schoenmakers, E., Huysmans, C., & Wj, V. D. V. (1999) · PubMed · Cited by 136
Noguchi, M., Yu, D. S., Hirayama, R., Ninomiya, Y., Sekine, E., Kubota, N., Andō, K., & Okayasu, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.094 · Cited by 136
Silva, I. U. D. (2002) · Nucleic Acids Research · doi:10.1093/nar/gkf479 · Cited by 122
Inhibitors of the Proteasome Suppress Homologous DNA Recombination in Mammalian Cells
Murakawa, Y., Sonoda, E., Barber, L. J., Zeng, W., Yokomori, K., Kimurâ, H., Niimi, A., Lehmann, A. R., Zhao, G., Hochegger, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1166 · Cited by 119
The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer
Hansen, L. T., Lundin, C., Spang‐Thomsen, M., Pétersen, L. N., & Helleday, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.11106 · Cited by 114
Self-citationRAD51 is involved in repair of damage associated with DNA replication in mammalian cells
Lundin, C., Schultz, N., Arnaudeau, C., Mohindra, A., Hansen, L. T., & Helleday, T. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(03)00313-9 · Cited by 113
Self-citationChoudhury, A., Zhao, H. W., Jalali, F., Rashid, S. A., Ran, J., Supiot, S., Kiltie, A. E., & Bristow, R. G. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0959 · Cited by 112
Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma
Yarde, D. N., Oliveira, V. A., Mathews, L., Wang, X., Villagra, A., Boulware, D. C., Shain, K. H., Hazlehurst, L., Alsina, M., Chen, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2616 · Cited by 110
Roos, W. P., Nikolova, T., Quirós, S., Naumann, S. C., Kiedron, O., Zdzienicka, M. Z., & Kaina, B. (2008) · DNA repair · doi:10.1016/j.dnarep.2008.09.003 · Cited by 106
Transcription-Associated Recombination Is Dependent on Replication in Mammalian Cells
Gottipati, P., Cassel, T. N., Savolainen, L., & Helleday, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00816-07 · Cited by 103
Self-citationTamulevicius, P., Wang, M., & Iliakis, G. E. (2007) · Radiation Research · doi:10.1667/rr0751.1 · Cited by 99
Bloom's syndrome. V. Surveillance for cancer in affected families
GERMAN, J. L., Bloom, D., & Passarge, E. (1977) · Clinical Genetics · doi:10.1111/j.1399-0004.1977.tb00919.x · Cited by 98
Al-Minawi, A. Z., Lee, Y.-F., Hakansson, D., Johansson, F., Lundin, C., Saleh-Gohari, N., Schultz, N. D., Jenssen, D., Bryant, H. E., Meuth, M., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp705 · Cited by 97
Self-citationJeggo, P. A., Caldecott, K. W., Pidsley, S. C., & Banks, G. R. (1989) · PubMed · Cited by 87
Defects in homologous recombination repair in mismatch-repair-deficient tumour cell lines
Mohindra, A., Hays, L. E., Phillips, E. N., Preston, B. D., Helleday, T., & Meuth, M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.18.2189 · Cited by 81
Self-citationFe65 is required for Tip60-directed histone H4 acetylation at DNA strand breaks
Stante, M., Minopoli, G., Passaro, F., Raia, M., Vecchio, L. D., & Russo, T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810869106 · Cited by 65
Arnaudeau, C., Miranda, E. T., Jenssen, D., & Helleday, T. (2000) · Mutation Research/DNA Repair · doi:10.1016/s0921-8777(00)00052-5 · Cited by 55
Self-citationHelleday, T., Arnaudeau, C., & Jenssen, D. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1809 · Cited by 51
Self-citationJohansson, F., Lagerqvist, A., Erixon, K., & Jenssen, D. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh154 · Cited by 40
Hansen, L. T., Lundin, C., Helleday, T., Poulsen, H. S., Sørensen, C. S., Pétersen, L. N., & Spang‐Thomsen, M. (2003) · Lung Cancer · doi:10.1016/s0169-5002(03)00026-6 · Cited by 37
Self-citationGenotoxicity of 1-nitronaphthalene in Chinese hamster V79 cells
Boyes, B. G., Rogers, C. G., & Stapley, R. (1991) · Mutation Research/Genetic Toxicology · doi:10.1016/0165-1218(91)90115-3 · Cited by 35
Zhang, H., Marra, G., Jiricny, J., Maher, V. M., & McCormick, J. J. (2000) · Carcinogenesis · doi:10.1093/carcin/21.9.1639 · Cited by 28
Savolainen, L., & Helleday, T. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn971 · Cited by 19
Self-citationMohindra, A. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddh022 · Cited by 18
Saleh-Gohari, N., & Helleday, T. (2004) · Oncogene · doi:10.1038/sj.onc.1208178 · Cited by 18
Self-citationBrca2 (XRCC11) deficiency results in enhanced mutagenesis
der Zwet, M. K.-V. (2003) · Mutagenesis · doi:10.1093/mutage/geg032 · Cited by 16
Cited by
DNA damage and the balance between survival and death in cancer biology
Roos, W. P., Thomas, A. D., & Kaina, B. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2015.2 · Cited by 1,189
Human RecQ Helicases in DNA Repair, Recombination, and Replication
Croteau, D. L., Popuri, V., Opresko, P. L., & Bohr, V. A. (2014) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-060713-035428 · Cited by 538
Mladenov, E., & Iliakis, G. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.02.005 · Cited by 381
Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1
Ying, S., Hamdy, F. C., & Helleday, T. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3417 · Cited by 346
Self-citationJiang, M., Jia, K., Wang, L., Li, W., Chen, B., Liu, Y., Wang, H., Zhao, S., He, Y., & Zhou, C. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.003 · Cited by 320
Metadata
- Authors
- Helleday, T.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-03-29
- Volume
- 31
- Issue
- 6
- Pages
- 955-960
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2165385395
- Cited by
- 291
- References
- 93
- FWCI
- 8.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.